E
Extrovis Private Ltd.
Extrovis is an integrated pharmaceutical company with quality products at our core and an ethical approach to all that we set out to achieve.
Country/Area ：India
Company Email ：admin@extrovis.com
Industry ：Manufacturing GeneralManufacturing
Company address ：BAHNHOF-PARK 4 6340 BAARSDNFSDNF
Company website ：*****
Company phone ：+41 417401119
Established ：-
Company Revenue ：$4,529,000
Number of employees ：<25
SIC Code ：28283
NAICS Code ：32325
Main Products ：--
Business Info
CIN ：U24304TG2017FTC115706
Registered State ：Telangana
Registrar Of Companies ：RoC-Hyderabad
Category ：Company limited by Shares
Sub Category ：Subsidiary of Foreign Company
Company Class ：Private
Company Status ：Active
Registered Office Address ：Flat No:7536, 2nd wing, 7th Block, Janapriya Apartments, Erragad Hyderabad Hyderabad TG IN 500018
Authorized Cap ：20000000.00
Paidup Capital ：387270.00
Web Summary
Q1: What is the global presence of Extrovis Group?
A1: The Extrovis Group operates worldwide with subsidiaries and affiliates in India, the EU, and the US.
Q2: Where is the Global Corporate Office of Extrovis Group located?
A2: The Global Corporate Office of Extrovis Group is located at Bahnhof-Park 4, Baar 6340, Switzerland.
Q3: What products does Extrovis Group focus on developing and commercializing?
A3: Extrovis Group focuses on the development and manufacturing of niche and differentiated finished-dose pharmaceutical products.
Q4: How many scientists and researchers are employed by Extrovis Group?
A4: Over 200 scientists and researchers are employed by Extrovis Group, dedicated to developing complex APIs and finished dosage form pharmaceutical products.
Q5: What is the value proposition of Extrovis Group?
A5: The value proposition of Extrovis Group lies in its dedication to creating value through the development and delivery of quality products that improve healthcare and medicine.
Q6: What regulatory requirements does Extrovis Group primarily focus on meeting?
A6: Extrovis Group primarily focuses on meeting the regulatory/clinical requirements of the US, with the possibility of leveraging competitiveness also on emerging markets.
Q7: How does Extrovis Group maintain its innovation in pharmaceutical process and intellectual property development?
A7: Extrovis concurrently maintains strategy and development teams in India, the EU, and the USA to keep it at the forefront of innovation in pharmaceutical process and intellectual property development.
Q8: What is the approach used by Extrovis Group's teams in different areas of expertise?
A8: Each team specializes in different areas of expertise, with full support and collaboration from all other divisions, particularly experienced Development Quality Assurance and Analytical Teams.
A1: The Extrovis Group operates worldwide with subsidiaries and affiliates in India, the EU, and the US.
Q2: Where is the Global Corporate Office of Extrovis Group located?
A2: The Global Corporate Office of Extrovis Group is located at Bahnhof-Park 4, Baar 6340, Switzerland.
Q3: What products does Extrovis Group focus on developing and commercializing?
A3: Extrovis Group focuses on the development and manufacturing of niche and differentiated finished-dose pharmaceutical products.
Q4: How many scientists and researchers are employed by Extrovis Group?
A4: Over 200 scientists and researchers are employed by Extrovis Group, dedicated to developing complex APIs and finished dosage form pharmaceutical products.
Q5: What is the value proposition of Extrovis Group?
A5: The value proposition of Extrovis Group lies in its dedication to creating value through the development and delivery of quality products that improve healthcare and medicine.
Q6: What regulatory requirements does Extrovis Group primarily focus on meeting?
A6: Extrovis Group primarily focuses on meeting the regulatory/clinical requirements of the US, with the possibility of leveraging competitiveness also on emerging markets.
Q7: How does Extrovis Group maintain its innovation in pharmaceutical process and intellectual property development?
A7: Extrovis concurrently maintains strategy and development teams in India, the EU, and the USA to keep it at the forefront of innovation in pharmaceutical process and intellectual property development.
Q8: What is the approach used by Extrovis Group's teams in different areas of expertise?
A8: Each team specializes in different areas of expertise, with full support and collaboration from all other divisions, particularly experienced Development Quality Assurance and Analytical Teams.
Customs Data
As a purchaser
As a Supplier
Get the Whole details
Contact
Total found ??? Contacts
All
Boss
Management
Procurement
Other
Get the Whole details
